NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,797 | +5.9% | 37,276 | +4.9% | 0.10% | +11.6% |
| Q2 2023 | $3,587 | +13.3% | 35,542 | +3.3% | 0.09% | +4.9% |
| Q1 2023 | $3,166 | +14.9% | 34,415 | +13.3% | 0.08% | +9.3% |
| Q4 2022 | $2,755 | -99.9% | 30,364 | -4.0% | 0.08% | +5.6% |
| Q3 2022 | $2,640,000 | +8.0% | 31,639 | +9.4% | 0.07% | -4.1% |
| Q2 2022 | $2,445,000 | +3.3% | 28,926 | +7.2% | 0.07% | +13.8% |
| Q1 2022 | $2,368,000 | +18.0% | 26,980 | +17.6% | 0.06% | +20.4% |
| Q4 2021 | $2,007,000 | -74.2% | 22,949 | -75.9% | 0.05% | -77.2% |
| Q3 2021 | $7,779,000 | -4.7% | 95,115 | +6.3% | 0.24% | -8.5% |
| Q2 2021 | $8,164,000 | -30.3% | 89,481 | -34.7% | 0.26% | -37.0% |
| Q1 2021 | $11,719,000 | -7.2% | 137,101 | +2.5% | 0.41% | -14.9% |
| Q4 2020 | $12,632,000 | +13.5% | 133,772 | +4.5% | 0.48% | -6.9% |
| Q3 2020 | $11,128,000 | -2.8% | 127,967 | -2.4% | 0.52% | -8.6% |
| Q2 2020 | $11,451,000 | -35.6% | 131,112 | -39.2% | 0.57% | -49.6% |
| Q1 2020 | $17,780,000 | -11.8% | 215,650 | +1.3% | 1.13% | +19.7% |
| Q4 2019 | $20,166,000 | +14.7% | 212,965 | +5.2% | 0.94% | -1.5% |
| Q3 2019 | $17,589,000 | +1.2% | 202,407 | +6.3% | 0.96% | -7.5% |
| Q2 2019 | $17,382,000 | +0.7% | 190,362 | +5.6% | 1.03% | -3.9% |
| Q1 2019 | $17,260,000 | +11.8% | 180,334 | +0.2% | 1.08% | -4.4% |
| Q4 2018 | $15,443,000 | +10.6% | 179,965 | +11.1% | 1.12% | +23.2% |
| Q3 2018 | $13,957,000 | +11.5% | 161,988 | -2.3% | 0.91% | +5.8% |
| Q2 2018 | $12,523,000 | +9.8% | 165,783 | +17.5% | 0.86% | 0.0% |
| Q1 2018 | $11,403,000 | +4.1% | 141,038 | +8.1% | 0.86% | -0.7% |
| Q4 2017 | $10,954,000 | -3.5% | 130,463 | -1.3% | 0.87% | -5.7% |
| Q3 2017 | $11,347,000 | +2.0% | 132,171 | -0.8% | 0.92% | +1.1% |
| Q2 2017 | $11,125,000 | +19.6% | 133,280 | +6.5% | 0.91% | +13.6% |
| Q1 2017 | $9,298,000 | +13.4% | 125,190 | +11.3% | 0.80% | +2.2% |
| Q4 2016 | $8,196,000 | -0.2% | 112,526 | +8.2% | 0.78% | -2.1% |
| Q3 2016 | $8,209,000 | -13.3% | 103,964 | -9.4% | 0.80% | -17.5% |
| Q2 2016 | $9,466,000 | +50.0% | 114,724 | +31.7% | 0.97% | +52.2% |
| Q1 2016 | $6,312,000 | -10.1% | 87,137 | +6.8% | 0.64% | -9.8% |
| Q4 2015 | $7,019,000 | +15.7% | 81,574 | +23.6% | 0.71% | +6.5% |
| Q3 2015 | $6,065,000 | +53.6% | 65,978 | +64.3% | 0.66% | +54.8% |
| Q2 2015 | $3,949,000 | – | 40,154 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |